Cargando…
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
Carcinoma of Unknown Primary (CUP) is a heterogeneous and metastatic disease where the primary site of origin is undetectable. Currently, chemotherapy is the only state-of-art treatment option for CUP patients. The molecular profiling of the tumour, particularly mutation detection, offers a new trea...
Autores principales: | Es, Hamidreza Aboulkheyr, Mahdizadeh, Hamid, Asl, Amir Abbas Hedayati, Totonchi, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302572/ https://www.ncbi.nlm.nih.gov/pubmed/34302033 http://dx.doi.org/10.1038/s41598-021-94678-4 |
Ejemplares similares
-
HNF4α is possibly the missing link between epithelial–mesenchymal transition and Warburg effect during hepatocarcinogenesis
por: Shokouhian, Bahare, et al.
Publicado: (2022) -
Prediction of the treatment response in ovarian cancer: a ctDNA approach
por: Sharbatoghli, Mina, et al.
Publicado: (2020) -
Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2022) -
Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’
por: Conway, Alicia-Marie, et al.
Publicado: (2018) -
Germline genetics of cancer of unknown primary (CUP) and its specific subtypes
por: Hemminki, Kari, et al.
Publicado: (2016)